Zhu P, Bény J L, Flammer J, Lüscher T F, Haefliger I O
Laboratory of Ocular Pharmacology and Physiology, University Eye Hospital, Basel, Switzerland.
Invest Ophthalmol Vis Sci. 1997 Aug;38(9):1761-7.
To assess the effects of K(+)-channel blockers on bradykinin-induced relaxations in porcine ciliary artery.
Vascular isometric forces were measured with a myograph system. Ciliary vascular rings were precontracted with thromboxane A2 analog (U 46619, 10(-7) M) to assess dose-dependent (10(-10)-3 x 10(-6) M) bradykinin-induced relaxation after addition of one of the following: the nitric oxide (NO) synthase inhibitor N omega-nitro-L-arginine methyl ester (L-NAME, 10(-4) M) or inactive enantiomer (D-NAME, 10(-4) M); the nonspecific K(+)-channel blocker tetra-ethylammonium (TEA, 10(-2) M); or the ATP-sensitive K(+)-channel blocker glibenclamide (10(-5) M). The effect of TEA on relaxations to the NO donor, sodium nitroprusside (SNP, 10(-10)-10(-4) M) was investigated. The membrane potential of vascular smooth muscle cells (VSMC) was recorded after exposure to bradykinin (2.5 x 10(-7) M).
Endothelium-dependent relaxations to bradykinin (maximal [max], 99% +/- 3%) were strongly inhibited by L-NAME (max, 39% +/- 4%, P < 0.01) and partially by TEA (max, 62% +/- 3%, P < 0.01) or glibenclamide (max, 77% +/- 4%, P < 0.01). Administration of glibenclamide plus L-NAME further suppressed bradykinin-induced relaxation (max, 23% +/- 6%; P < 0.01), whereas TEA and L-NAME (max, 6% +/- 2%; P < 0.01) abolished the relaxation. SNP relaxations were unaffected by TEA. Bradykinin had no effect on the membrane potential of VSMC.
In porcine ciliary artery, the endothelium-dependent relaxations to bradykinin are primarily mediated by NO and involve K(+)-channels. As only relaxations to bradykinin, but not those mediated by SNP, were inhibited by TEA, this implies that K(+)-channel blockers most likely affect the bradykinin-evoked NO production or release by the endothelium.
评估钾通道阻滞剂对猪睫状动脉中缓激肽诱导的舒张作用的影响。
使用肌动描记系统测量血管等长力。用血栓素A2类似物(U 46619,10⁻⁷ M)预收缩睫状血管环,在加入以下物质之一后评估剂量依赖性(10⁻¹⁰ - 3×10⁻⁶ M)的缓激肽诱导的舒张:一氧化氮(NO)合酶抑制剂Nω-硝基-L-精氨酸甲酯(L-NAME,10⁻⁴ M)或无活性对映体(D-NAME,10⁻⁴ M);非特异性钾通道阻滞剂四乙铵(TEA,10⁻² M);或ATP敏感性钾通道阻滞剂格列本脲(10⁻⁵ M)。研究了TEA对向NO供体硝普钠(SNP,10⁻¹⁰ - 10⁻⁴ M)舒张的影响。在暴露于缓激肽(2.5×10⁻⁷ M)后记录血管平滑肌细胞(VSMC)的膜电位。
L-NAME强烈抑制对缓激肽的内皮依赖性舒张(最大[max],99%±3%)(最大,39%±4%,P<0.01),TEA(最大,62%±3%,P<0.01)或格列本脲(最大,77%±4%,P<0.01)部分抑制。给予格列本脲加L-NAME进一步抑制缓激肽诱导的舒张(最大,23%±6%;P<0.01),而TEA和L-NAME(最大,6%±2%;P<0.01)消除了舒张。SNP舒张不受TEA影响。缓激肽对VSMC的膜电位无影响。
在猪睫状动脉中,对缓激肽的内皮依赖性舒张主要由NO介导并涉及钾通道。由于只有对缓激肽的舒张,而不是由SNP介导的舒张,被TEA抑制,这意味着钾通道阻滞剂很可能影响缓激肽诱发的内皮NO生成或释放。